GSK vs OBK · P/E 13, $103.31B cap vs P/E 18, rev $267.0M
GlaxoSmithKline PLC ADR (GSK) versus Origin Bancorp, Inc. (OBK) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Origin Bancorp, Inc. (OBK) is a banks - regional company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported OBK revenue for 2026-06-30 was $267.0M. Net income was $61.5M. OBK currently screens at market cap $1.44B and trailing P/E 18.0.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. OBK currently screens at market cap $1.44B and trailing P/E 18.0.
Not investment advice. Open the GSK and OBK stock pages for the full models.
Not investment advice.